{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:53:31Z","timestamp":1792011211531,"version":"4.4.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008980","name":"Medical College of Wisconsin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008980","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgery"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.surg.2026.110646","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T09:45:41Z","timestamp":1789119941000},"page":"110646","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effectiveness of estimated blood volume\u2013guided prophylactic enoxaparin dosing in patients following minimally invasive surgery"],"prefix":"10.1016","author":[{"given":"Laken","family":"Anderson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tammy","family":"Kindel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Peppard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Rein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surg.2026.110646_bib1","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1177\/00031348251339525","article-title":"Venous thromboembolism after bariatric surgery: an analysis of predictors and trends in two large datasets","volume":"91","author":"Leslie","year":"2025","journal-title":"Am Surg"},{"key":"10.1016\/j.surg.2026.110646_bib2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.soard.2025.10.007","article-title":"Heart failure is a major risk factor for postoperative venous thromboembolism in bariatric surgery patients","volume":"22","author":"Nor Hanipah","year":"2025","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.surg.2026.110646_bib3","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1007\/s11695-024-07184-7","article-title":"Cumulative incidence of venous thromboembolic events in-hospital, and at 1, 3, 6, and 12 months after metabolic and bariatric surgery: systematic review and meta-analysis","volume":"34","author":"El Ansari","year":"2024","journal-title":"Obes Surg"},{"issue":"1 Suppl","key":"10.1016\/j.surg.2026.110646_bib4","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1378\/chest.119.1_suppl.3S","article-title":"Grades of recommendation for antithrombotic agents","volume":"119","author":"Guyatt","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.surg.2026.110646_bib5","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1067\/mcp.2002.127114","article-title":"The pharmacokinetics and pharmacodynamics of enoxaparin in obese volunteers","volume":"72","author":"Sanderink","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.surg.2026.110646_bib6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.soard.2021.10.023","article-title":"The American Society for Metabolic and Bariatric Surgery updated position statement on perioperative venous thromboembolism prophylaxis","volume":"18","author":"Aminian","year":"2022","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/j.surg.2026.110646_bib7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/1076029614568713","article-title":"Evaluation and pharmacokinetics of treatment-dose enoxaparin in hospitalized patients with morbid obesity","volume":"21","author":"Thompson-Moore","year":"2015","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.surg.2026.110646_bib8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1177\/87551225251328255","article-title":"Prophylactic enoxaparin dosing and anti-Xa levels in medicine patients with obesity","volume":"41","author":"Phyo","year":"2025","journal-title":"J Pharm Technol"},{"key":"10.1016\/j.surg.2026.110646_bib9","first-page":"133","article-title":"Evaluation of anti-Xa target attainment with prophylactic enoxaparin dosing regimens in morbidly obese patients","volume":"12","author":"Sabers","year":"2024","journal-title":"Pharmacy (Basel)"},{"key":"10.1016\/j.surg.2026.110646_bib10","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/phar.1658","article-title":"Monitoring enoxaparin with antifactor Xa levels in obese patients","volume":"35","author":"Lee","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.surg.2026.110646_bib11","first-page":"224","article-title":"Prediction of blood volume in normal human adults","volume":"51","author":"Nadler","year":"1962","journal-title":"Surgery"},{"key":"10.1016\/j.surg.2026.110646_bib12","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jss.2023.01.018","article-title":"Effectiveness of body mass index-based prophylactic enoxaparin dosing in bariatric surgery patients","volume":"287","author":"Chang","year":"2023","journal-title":"J Surg Res"},{"key":"10.1016\/j.surg.2026.110646_bib13","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/ajhp\/zxad119","article-title":"Evaluation of a novel blood volume\u2013based enoxaparin dosing guideline for venous thromboembolism prophylaxis in trauma patients","volume":"80","author":"Langenstroer","year":"2023","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.surg.2026.110646_bib14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/phar.2904","article-title":"Multicenter study evaluating target attainment of anti-factor Xa levels using various enoxaparin prophylactic dosing practices in adult trauma patients","volume":"44","author":"Chanas","year":"2024","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.surg.2026.110646_bib15","article-title":"Evaluation of prophylactic enoxaparin anti-Xa levels in individuals \u2265150 kg","author":"Olson","year":"2026","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.surg.2026.110646_bib16","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s11239-014-1117-y","article-title":"Assessing an enoxaparin dosing protocol in morbidly obese patients","volume":"39","author":"Lalama","year":"2015","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.surg.2026.110646_bib17","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/TA.0000000000003738","article-title":"One size does not fit all: sex bias in pharmacologic venous thromboembolism prophylaxis","volume":"94","author":"Modi","year":"2023","journal-title":"J Trauma Acute Care Surg"},{"key":"10.1016\/j.surg.2026.110646_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1377232","article-title":"How enoxaparin underdosing and sex contribute to achieving therapeutic anti-Xa levels","volume":"15","author":"Tinchon","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.surg.2026.110646_bib19","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/10600280231189488","article-title":"Risk stratification for supratherapeutic peak anti-Xa levels in adult patients on therapeutic enoxaparin","volume":"58","author":"Sheredy","year":"2024","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.surg.2026.110646_bib20","series-title":"Prescribing Information","year":"2026"},{"key":"10.1016\/j.surg.2026.110646_bib21","doi-asserted-by":"crossref","first-page":"e682","DOI":"10.1097\/SLA.0000000000004589","article-title":"Low anti-factor Xa level predicts 90-day symptomatic venous thromboembolism in surgical patients receiving enoxaparin prophylaxis: a pooled analysis of eight clinical trials","volume":"6","author":"Pannucci","year":"2022","journal-title":"Ann Surg"}],"container-title":["Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606026005714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039606026005714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T20:38:55Z","timestamp":1792010335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039606026005714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":21,"alternative-id":["S0039606026005714"],"URL":"https:\/\/doi.org\/10.1016\/j.surg.2026.110646","relation":{},"ISSN":["0039-6060"],"issn-type":[{"value":"0039-6060","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of estimated blood volume\u2013guided prophylactic enoxaparin dosing in patients following minimally invasive surgery","name":"articletitle","label":"Article Title"},{"value":"Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surg.2026.110646","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110646"}}